首页> ACS applied materials & interfaces> Injectable Magnolol-Peptide Hydrogel as a Minimally Invasive Treatment for Doxorubicin-Induced Cardiomyopathy via Inhibition of Aberrant Mitochondrial Fission.

Injectable Magnolol-Peptide Hydrogel as a Minimally Invasive Treatment for Doxorubicin-Induced Cardiomyopathy via Inhibition of Aberrant Mitochondrial Fission.

导出 LinkOut

翻译打印收藏纠错

第一作者： Yongquan,Hua

第一单位： Department of Cardiology, The Affiliated Guangdong Second Provincial General Hospital of Jinan University, Guangzhou 510317, China.

作者： Yongquan,Hua ^[1] ; Huiming,Chen ^[2] ; Yuanyuan,Wu ^[2] ; Yajie,Wu ^[2] ; Chenyazhuo,Hu ^[2] ; Yinghua,Zeng ^[2] ; Mingzhi,Shen ^[3] ; Jie,Zhan ^[4] ; Rongsen,Meng ^[1] ; Yanbin,Cai ^[2]

作者单位： Department of Cardiology, The Affiliated Guangdong Second Provincial General Hospital of Jinan University, Guangzhou 510317, China. ^[1] Guangdong Provincial Biomedical Engineering Technology Research Center for Cardiovascular Disease, Department of Cardiology and Laboratory of Heart Center, Zhujiang Hospital, Southern Medical University, Guangzhou 510280, China. ^[2] Department of General Practice, Hainan Hospital of Chinese PLA General Hosptial, Sanya 572013, China. ^[3] Department of Laboratory Medicine, Guangdong Provincial Key Laboratory of Precision Medical Diagnostics, Guangdong Engineering and Technology Research Center for Rapid Diagnostic Biosensors, Guangdong Provincial Key Laboratory of Single-cell and Extracellular Vesicles, Nanfang Hospital, Southern Medical University, Guangzhou 510515, China. ^[4]

关键词 cardiac injury treatment doxorubicin cardiotoxicity mitochondrial fission peptide–drug conjugate self-assembly hydrogel